More research is needed before GLP-1 therapies could be considered for endometriosis
World Business web page
I say these things, again, never to evoke fear, but so that we have the knowledge to be aware of our bodies and work with them in a powerful, educated way
Probably the game-changing study in the New England Journal, which I was corresponding author on, was STEP 1, which actually launched semaglutide to the world which for the first time caused a result in a 15% weight loss at the end of a year
Together, these developments signal the beginning of a transformative era in MASH treatment, where patients may soon benefit from a diverse portfolio of targeted therapies designed to halt or even reverse disease progression
Comprehensive skin regeneration and collagen support